Pain management with opioid analgesics: Balancing risk & benefit

Steven P. Stanos, David A Fishbain, Scott M. Fishman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The "opioid pendulum" swings between providing adequate pain relief and preventing addiction, without solving either problem sufficiently. Policies to address prescription drug abuse in the United States sometimes appear to contradict a practice environment in which chronic pain can be adequately treated. Pharmacovigilance when prescribing controlled substances for chronic pain requires physicians to first make a risk/benefit analysis and then to reassess during ongoing treatment. It is important that physicians document this analysis with transparency so regulators can see that risk is being assessed and managed. Physicians must balance the benefits and risks of COAT so that they can continue to treat pain effectively and improve functional outcomes, while at the same time avoid indiscriminate prescribing. Physicians have an obligation to be thorough, thoughtful, logically consistent, and careful-but there is no realistic expectation that they will always be "right." Advances in the science and art of medicine emphasize rational patient assessment and selection for treatment, the benefits and limitations of pharmacologic and nonpharmacologic management, and careful monitoring. Even small changes to clinical practice can promote safe controlled substances prescribing, and will likely improve the overall standard of care.

Original languageEnglish
JournalAmerican Journal of Physical Medicine and Rehabilitation
Volume88
Issue number3 SUPPL. 2
DOIs
StatePublished - Mar 1 2009
Externally publishedYes

Fingerprint

Pain Management
Opioid Analgesics
Controlled Substances
Physicians
Chronic Pain
Patient Selection
Prescription Drug Misuse
Pharmacovigilance
Pain
Standard of Care
Art
Medicine
Therapeutics

Keywords

  • Chronic pain
  • Drug abuse
  • Opioid analgesics
  • Pain management

ASJC Scopus subject areas

  • Rehabilitation
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Pain management with opioid analgesics : Balancing risk & benefit. / Stanos, Steven P.; Fishbain, David A; Fishman, Scott M.

In: American Journal of Physical Medicine and Rehabilitation, Vol. 88, No. 3 SUPPL. 2, 01.03.2009.

Research output: Contribution to journalArticle

Stanos, Steven P. ; Fishbain, David A ; Fishman, Scott M. / Pain management with opioid analgesics : Balancing risk & benefit. In: American Journal of Physical Medicine and Rehabilitation. 2009 ; Vol. 88, No. 3 SUPPL. 2.
@article{805ec8b611c545cb907af3e8585ad9d4,
title = "Pain management with opioid analgesics: Balancing risk & benefit",
abstract = "The {"}opioid pendulum{"} swings between providing adequate pain relief and preventing addiction, without solving either problem sufficiently. Policies to address prescription drug abuse in the United States sometimes appear to contradict a practice environment in which chronic pain can be adequately treated. Pharmacovigilance when prescribing controlled substances for chronic pain requires physicians to first make a risk/benefit analysis and then to reassess during ongoing treatment. It is important that physicians document this analysis with transparency so regulators can see that risk is being assessed and managed. Physicians must balance the benefits and risks of COAT so that they can continue to treat pain effectively and improve functional outcomes, while at the same time avoid indiscriminate prescribing. Physicians have an obligation to be thorough, thoughtful, logically consistent, and careful-but there is no realistic expectation that they will always be {"}right.{"} Advances in the science and art of medicine emphasize rational patient assessment and selection for treatment, the benefits and limitations of pharmacologic and nonpharmacologic management, and careful monitoring. Even small changes to clinical practice can promote safe controlled substances prescribing, and will likely improve the overall standard of care.",
keywords = "Chronic pain, Drug abuse, Opioid analgesics, Pain management",
author = "Stanos, {Steven P.} and Fishbain, {David A} and Fishman, {Scott M.}",
year = "2009",
month = "3",
day = "1",
doi = "10.1097/PHM.0b013e318198dcf7",
language = "English",
volume = "88",
journal = "American Journal of Physical Medicine and Rehabilitation",
issn = "0894-9115",
publisher = "Lippincott Williams and Wilkins",
number = "3 SUPPL. 2",

}

TY - JOUR

T1 - Pain management with opioid analgesics

T2 - Balancing risk & benefit

AU - Stanos, Steven P.

AU - Fishbain, David A

AU - Fishman, Scott M.

PY - 2009/3/1

Y1 - 2009/3/1

N2 - The "opioid pendulum" swings between providing adequate pain relief and preventing addiction, without solving either problem sufficiently. Policies to address prescription drug abuse in the United States sometimes appear to contradict a practice environment in which chronic pain can be adequately treated. Pharmacovigilance when prescribing controlled substances for chronic pain requires physicians to first make a risk/benefit analysis and then to reassess during ongoing treatment. It is important that physicians document this analysis with transparency so regulators can see that risk is being assessed and managed. Physicians must balance the benefits and risks of COAT so that they can continue to treat pain effectively and improve functional outcomes, while at the same time avoid indiscriminate prescribing. Physicians have an obligation to be thorough, thoughtful, logically consistent, and careful-but there is no realistic expectation that they will always be "right." Advances in the science and art of medicine emphasize rational patient assessment and selection for treatment, the benefits and limitations of pharmacologic and nonpharmacologic management, and careful monitoring. Even small changes to clinical practice can promote safe controlled substances prescribing, and will likely improve the overall standard of care.

AB - The "opioid pendulum" swings between providing adequate pain relief and preventing addiction, without solving either problem sufficiently. Policies to address prescription drug abuse in the United States sometimes appear to contradict a practice environment in which chronic pain can be adequately treated. Pharmacovigilance when prescribing controlled substances for chronic pain requires physicians to first make a risk/benefit analysis and then to reassess during ongoing treatment. It is important that physicians document this analysis with transparency so regulators can see that risk is being assessed and managed. Physicians must balance the benefits and risks of COAT so that they can continue to treat pain effectively and improve functional outcomes, while at the same time avoid indiscriminate prescribing. Physicians have an obligation to be thorough, thoughtful, logically consistent, and careful-but there is no realistic expectation that they will always be "right." Advances in the science and art of medicine emphasize rational patient assessment and selection for treatment, the benefits and limitations of pharmacologic and nonpharmacologic management, and careful monitoring. Even small changes to clinical practice can promote safe controlled substances prescribing, and will likely improve the overall standard of care.

KW - Chronic pain

KW - Drug abuse

KW - Opioid analgesics

KW - Pain management

UR - http://www.scopus.com/inward/record.url?scp=62549132714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62549132714&partnerID=8YFLogxK

U2 - 10.1097/PHM.0b013e318198dcf7

DO - 10.1097/PHM.0b013e318198dcf7

M3 - Article

AN - SCOPUS:62549132714

VL - 88

JO - American Journal of Physical Medicine and Rehabilitation

JF - American Journal of Physical Medicine and Rehabilitation

SN - 0894-9115

IS - 3 SUPPL. 2

ER -